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ORIGINAL ARTICLE
Influence of Maternal Lifestyle and Diet on 
Perinatal DNA Methylation Signatures Associated 
With Childhood Arterial Stiffness at 8 to 9 Years
Robert Murray, Negusse Kitaba , Elie Antoun , Philip Titcombe, Sheila Barton, Cyrus Cooper, Hazel M. Inskip ,  
Graham C. Burdge, Pamela A. Mahon , John Deanfield, Julian P. Halcox, Elizabeth A. Ellins, Jennifer Bryant ,  
Charles Peebles, Karen Lillycrop,* Keith M. Godfrey ,* Mark A. Hanson *; EpiGen Consortium
ABSTRACT: Increases in aortic pulse wave velocity, a measure of arterial stiffness, can lead to elevated systolic blood pressure 
and increased cardiac afterload in adulthood. These changes are detectable in childhood and potentially originate in utero, 
where an adverse early life environment can alter DNA methylation patterns detectable at birth. Here, analysis of epigenome-
wide methylation patterns using umbilical cord blood DNA from 470 participants in the Southampton’s Women’s Survey 
identified differential methylation patterns associated with systolic blood pressure, pulse pressure, arterial distensibility, and 
descending aorta pulse wave velocity measured by magnetic resonance imaging at 8 to 9 years. Perinatal methylation levels 
at 16 CpG loci were associated with descending aorta pulse wave velocity, with identified CpG sites enriched in pathways 
involved in DNA repair (P=9.03×10−11). The most significant association was with cg20793626 methylation (within protein 
phosphatase, Mg2+/Mn2+ dependent 1D; β=−0.05 m/s/1% methylation change, [95% CI, −0.09 to −0.02]). Genetic 
variation was also examined but had a minor influence on these observations. Eight pulse wave velocity-linked dmCpGs were 
associated with prenatal modifiable risk factors, with cg08509237 methylation (within palmitoyl-protein thioesterase-2) 
associated with maternal oily fish consumption in early and late pregnancy. Lower oily fish consumption in early pregnancy 
modified the relationship between methylation and pulse wave velocity, with lower consumption strengthening the association 
between cg08509237 methylation and increased pulse wave velocity. In conclusion, measurement of perinatal DNA 
methylation signatures has utility in identifying infants who might benefit from preventive interventions to reduce risk of later 
cardiovascular disease, and modifiable maternal factors can reduce this risk in the child. (Hypertension. 2021;78:00–00. 
DOI: 10.1161/HYPERTENSIONAHA.121.17396.) • Data Supplement
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Cardiovascular disease (CVD) is a leading cause of death worldwide and the single largest cause of noncommunicable disease deaths.1 Early mark-
ers of CVD risk are important to identify individuals at 
particular risk who may benefit from preventive inter-
ventions. Increased arterial stiffness, which augments 
systolic blood pressure, increases cardiac afterload and 
leads to hemodynamic dysfunction, is a strong predictor 
of cardiovascular events and all-cause mortality2,3 and 
contributes significantly to the global chronic CVD bur-
den.4 Raised aortic pulse wave velocity (aPWV), the most 
widely used measure of increased arterial stiffness,3,5,6 
is positively associated with carotid and aortic plaque 
formation, calcification, and coronary atherosclerosis.7,8 
Longitudinal studies have shown that increased aPWV 
is one of the earliest detectable measures of vascular 
pathology9 and is a significant independent risk factor 
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While clinical presentation of CVD occurs primarily in 
later life, this is preceded by subclinical changes in both car-
diovascular structure and function. Many of these changes 
can be detected in childhood,12,13 consistent with the thesis 
that CVD risk may partly originate in utero.14 Modifiable pre-
natal risk factors such as maternal body mass index (BMI) 
and gestational weight gain, smoking, as well as dietary 
components such as vitamin D, folic acid, and consumption 
of oily fish, the main dietary source of the polyunsaturated 
fatty acids, eicosapentaenoic acid (EPA), and docosahexae-
noic acid (DHA),15–17 have been shown to influence later 
CVD risk markers such as carotid intima-media thickness,18 
aPWV,19 and elevated blood pressure (BP)20 in children.
One mechanism by which the early life environment 
has been suggested to induce persistent changes in 
offspring phenotype is through altered epigenetic regu-
lation of gene expression.21,22 Studies in both humans 
and animals have reported that aspects of the prenatal 
environment are associated with altered DNA methyla-
tion and subsequent disease risk.23–25 For example, we 
previously showed that DNA methylation at birth at CpG 
loci within the promoter of ANRIL, a long noncoding RNA 
with strong genetic links to CVD,26 was associated with 
arterial stiffness in children aged 8 to 9 years27; further-
more, maternal cholesterol levels have been correlated 
with early fetal atherogenesis and methylation of key 
genes in fetal cholesterol metabolism.28 Taken together, 
these studies examining candidate genes suggest that it 
is possible to identify epigenetic markers in early life that 
are predictive of later CVD risk. A systematic approach 
to identify alterations throughout the methylome could 
allow earlier risk stratification and provide insights into 
modifiable prenatal factors that may attenuate such risk, 
providing a basis for developing future interventions. 
To determine whether differential methylation of CpG 
loci at birth is associated with CVD risk factors in child-
hood, we performed the first comprehensive analysis of 
the relationship between epigenome-wide DNA meth-
ylation, measured at birth in umbilical cord blood DNA, 
and detailed assessment of cardiovascular structure and 
function in the children at age 8 to 9 years, using data 
from the UK Southampton Women’s Survey (SWS). The 
Nonstandard Abbreviations and Acronyms
ANRIL  antisense non-coding RNA in the INK4 
locus
aPWV aortic pulse wave velocity
BMI body mass index
BP blood pressure
CpG  cytosine base followed by a guanine 




FDR false discovery rate
FMD flow-mediated dilatation
PPI protein-protein interaction
SWS Southampton Women’s Survey
Novelty and Significance
What Is New?
• Identified at birth 16 novel CpG sites with methylation 
levels associated with aortic pulse wave velocity, an 
early measure of arterial stiffness linked to elevated 
systolic blood pressure and increased cardiac afterload.
• Developed a multivariate model that combines differ-
ential methylation at 14 CpG sites which, with other 
covariates, explained 45.4% of the variance in late 
childhood pulse wave velocity, potentially providing a 
strong predictive tool of future risk.
• Found evidence that maternal weight gain and nutri-
tion during pregnancy influenced these early epigen-
etic biomarkers of cardiovascular risk.
What Is Relevant?
• Epigenome-wide association study examining meth-
ylation levels at birth finding associations with later 
measures of systolic and diastolic blood pressure, as 
well as pulse pressure.
• First study to use magnetic resonance imaging-derived 
measures of pulse wave velocity to identify epigenetic 
biomarkers of arterial stiffness, a driver of increased 
systolic blood pressure and cardiac afterload in later 
life, as well as an independent risk factor for cardio-
vascular disease.
• Study examined both fixed and modifiable factors that 
could influence these epigenetic marks, identifying an 
underlying interaction of maternal diet with methylation 
and later pulse wave velocity.
Summary
Analysis of DNA methylation levels measured at birth 
in a highly characterized cohort with in-depth mea-
sures of cardiovascular structure and function in late 
childhood identified epigenetic marks associated with 
pulse wave velocity, blood pressure, pulse pressure, 
arterial distensibility, and heart rate. Examination of 
both fixed and modifiable prenatal factors identified a 
relationship between components of the maternal diet, 




 http://ahajournals.org by on A
ugust 10, 2021
ORIGINAL ARTICLE
Hypertension. 2021;78:00–00. DOI: 10.1161/HYPERTENSIONAHA.121.17396 September 2021  3
Murray et al Epigenetic Markers of Child’s Arterial Stiffness
relationship between differentially methylated CpG loci 
associated with CVD risk and fixed genetic differences as 
well as modifiable factors, specifically maternal adiposity 
and diet during pregnancy, was then examined to explore 
whether modifiable lifestyle factors during pregnancy 
could influence the child’s methylation of these marks at 
birth and thus potentially their CVD risk in later childhood.
METHODS
Anonymized data and materials have been made publicly avail-
able at the Gene Expression Omnibus under accession number 
GSE154915 and can be accessed at https://www.ncbi.nlm.
nih.gov/geo/.
Study Cohort
The SWS is an ongoing prospective cohort study of 12 583, ini-
tially nonpregnant, women aged 20 to 34 years living in the city 
of Southampton, United Kingdom.2 Assessments of lifestyle, 
diet,30,31 and anthropometry were performed at study entry 
(April 1998–December 2002). Women who subsequently 
became pregnant were followed through pregnancy and their 
offspring were followed up during infancy and childhood. Here, 
we focus on data from the cardiovascular follow-up of a sub-
sample of the children aged 8 to 9 years.
Maternal Characteristics, Diet, Micronutrient 
Status, and Plasma Fatty Acid Composition
Full details of the ascertainment of maternal BMI, weight gain 
in pregnancy, smoking, dietary intake assessment, serum vitamin 
D, and vitamin B12 status are available in the Data Supplement. 
Measurements of maternal plasma EPA and DHA during preg-
nancy were available in a subset of individuals in whom DNA 
methylation was measured (early pregnancy, n=316; late preg-
nancy, n=377). As described previously,32 the concentrations of 
DHA and EPA were calculated from the ratio of their peak areas 
to the peak area of the internal standard, multiplied by the amount 
of standard and corrected for the volume of plasma extracted.
Cardiovascular Measures in the SWS Cohort
Magnetic resonance imaging pulse wave velocity (aPWV), arte-
rial distensibility, BP, carotid intima-media thickness, flow-medi-
ated dilatation (FMD), and reactive hyperemia were measured 
in the children at 8 to 9 years of age. Full details are available 
in the Data Supplement.
DNA Extraction
Genomic DNA was extracted from the buffy coat of umbili-
cal cord blood samples using the QIAamp Blood DNA mini kit 
(Qiagen). Quality of the genomic DNA was assessed by agarose 
gel electrophoresis, and quantity of genomic DNA was checked 
on the NanoDrop ND-1000 (NanoDrop Technologies).
Measurement of DNA Methylation
DNA from cord blood was bisulfite converted using the 
Zymo EZ DNA Methylation-Gold kit. The Infinium Human 
MethylationEPIC BeadChip array (Illumina Inc, San Diego, CA) 
was used to analyze DNA methylation levels. Quality control, fil-
tering, and normalization of the methylation data are described 
in the Data Supplement.33–42 Probes located on SNPs, on the 
X or Y chromosome and cross-reactive probes were discarded.
Genotyping
SNP genotyping was performed using Human OminiExpress-
24v1.2 at Edinburgh Clinical Research Facility. Genotyping call 
was analyzed in Illumina Genome Studio 2.0.2 using genotyp-
ing Module 2.0.2 following the manufacturer technical note.43 
PLINK version 1.9 beta44 was used for SNP data management 
and quality control.
Statistical Analysis
Regression models using limma41 were run with methylation 
as the outcome variable. All models included the following as 
covariates: maternal smoking, child’s sex, age at measure-
ments, batch effect, position on chip and the predicted values 
for B cell, CD4 T cell, CD8 T cell, monocyte, natural killer cell, 
and nucleated red blood cell counts. The analysis was con-
trolled for multiple testing with the Benjamini-Hochberg adjust-
ment for false discovery rate (FDR). Linear regression was 
used to obtain an estimate of phenotypic variance explained by 
multiple dmCpGs, alongside other model components, associ-
ated with aPWV. The 16 dmCpG sites associated with aPWV 
(FDR adjusted P value ≤0.05) were included in a linear regres-
sion model alongside covariates listed above. The aim of the 
model was to optimize the variance explained in the outcome; 
to do so, the least significant dmCpG was removed from the 
model and the estimate for phenotypic variance explained by 
the model was examined. This process was repeated until the 
removal of a dmCpG would cause a reduction in the total vari-
ance explained by the model.
To investigate the influence of SNPs on methylation, GEM45 
Bioconductor/R package was applied with a filter for ≥0.05 
minor allele frequency and Bonferroni correction for multiple 
testing. To determine the relationship between genetic variation 
and methylation levels identified CpG sites, multivariate regres-
sion was performed, controlling for array batch, position, blood 
cell components, sex of child, and smoking in pregnancy. Where 
multiple SNPs were associated with individual CpG loci, prin-
ciple component analysis was performed to identify principle 
components that explained ≥70% of the proportion of variance 
(Table S3 in the Data Supplement).
Network and Gene Ontology Enrichment
Protein-protein interaction networks (PPI) were examined 
using the Search Tool for the Retrieval of Interacting Genes/
Proteins.46 Genes annotated to dmCpGs associated with 
outcomes (FDR adjusted P value ≤0.25) were entered into 
Search Tool for the Retrieval of Interacting Genes/Proteins 
and visualized in Cytoscape.47 The properties of the PPI net-
work were calculated under default parameters, and only con-
nected nodes that generated a network with a PPI enrichment 
P≤0.05 were retained for subsequent analysis. Large net-
works were further segmented using the MCODE algorithm48 
in Cytoscape using default parameters. Enriched gene ontol-
ogy terms were determined using BiNGO49 to examine over-
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RESULTS
Study Participants
DNA was extracted from cord blood samples from SWS 
infants who had measures of cardiovascular structure or 
function at a median age of 9.2 years. Table 1 shows char-
acteristics of the 470 participants for which DNA methyla-
tion data was available; Table S1 provides a comparison of 
SWS participants with and without methylation data.
Relationship Between Cord Blood DNA 
Methylation and aPWV at 8 to 9 Years
Cord blood DNA methylation was analyzed in relation to the 
measures of arterial stiffness and structure at 8 to 9 years of 
age. There were 16 differentially methylated CpG dinucleo-
tides (dmCpGs) with an FDR of ≤0.05 associated with aPWV 
at 8 to 9 years (Figure 1A; Table 2). The most significantly 
associated dmCpGs were cg20793626 (Figure 1C), located 
within the gene body of protein phosphatase, Mg2+/Mn2+ 
dependent 1D (PPM1D), and cg21851496, located within 
the north shore of syntabulin (SYBU). The other identified 
dmCpGs were primarily located within open seas or, when 
associated with a gene, within CpG islands (Figure 1B). A 
1% decrease in methylation of cg20793626 was associ-
ated with a 0.06 m/s increase in aPWV, while the largest 
effect size observed was with methylation of cg19669439 
within the promoter of β-transducin repeat containing E3 
ubiquitin protein ligase (BTRC), where an increase of 1% 
methylation was associated with an increase in aPWV of 
0.24 m/s (Table 3). All associations with aPWV remained 
significant after adjustment for child’s height, BMI at 8 to 
9 years, maternal age at birth, maternal educational attain-
ment, and parity (Table S2A). Analysis was also performed to 
detect differentially methylated regions50; however, no differ-
entially methylated regions were detected (data not shown).
Enrichment of aPWV-Associated dmCpGs 
in Pathways Associated With DNA Repair, 
Metabolic Process, and Protein Transport
To gain a better understanding of the functional signifi-
cance of the methylation changes, genes associated with 
the aPWV-associated dmCpGs at an FDR ≤0.25 were 
entered into Search Tool for the Retrieval of Interacting 
Genes/Proteins to generate a PPI network (Figure S2). 
Of the 874 CpGs associated with aPWV (FDR ≤0.25), 
628 were associated with a unique gene. The resulting 
PPI network (FDR ≤0.05) had 540 nodes and 1011 inter-
actions. To determine key modules in the PPI network, the 
network was subdivided into clusters using the MCODE 
algorithm, resulting in 12 individual modules being identi-
fied. The significant gene ontology terms associated with 
these clusters were DNA repair (FDR, 9.03×10−11), cellu-
lar macromolecular metabolic process (FDR, 4.31×10−07), 
endoplasmic reticulum to Golgi mediated transport (FDR, 
1.87×10−07), positive regulation of catalytic activity (FDR, 
1.07×10−05), and carbohydrate metabolic process (FDR, 
2.51×10−03). There were limited PPIs related to dmCpGs 
associated with arterial distensibility or the carotid disten-
sibility coefficient, with no enrichment of pathways.
A Combined Model for DNA Methylation 
Signature at Birth Predictive of aPWV at 8 to 9 
Years
Multivariate linear regression was used to assess the 
variance in aPWV explained by the dmCpGs which 





N (%) or  
median (5th–95th 
percentile)
Ethnicity White 470 (100%)
Smoking in pregnancy No 407 (86.6%)
Yes 63 (13.4%)
Women’s prepregnancy BMI, kg/m2 470 24.1 (19.6–35.1)
Pregnancy weight gain, kg 448 11.7 (3.9–23.3)
Early pregnancy: Oily fish portions/wk 386 0.5 (0.0–4.5)
Late pregnancy: Oily fish portions/wk 463 0.5 (0.0–4.5)
Early pregnancy: serum vitamin B12, pg/mL 367 370.5 (194.4–605.2)
Late pregnancy: serum vitamin B12, pg/mL 418 166.0 (94.0–286.0)
Early pregnancy: serum vitamin D, nmol/L 372 63.5 (25.5–110.0)
Late pregnancy: serum vitamin D, nmol/L 443 65.7 (28.0–124.0)
Early pregnancy: plasma EPA, µg/mL 316 13.0 (5.9–30.0)
Late pregnancy: plasma EPA, µg/mL 377 5.3 (2.1–15.7)
Early pregnancy: plasma DHA, µg/mL 316 80.3 (46.8–135.2)
Late pregnancy: plasma DHA, µg/mL 377 54.6 (28.0–107.8)
Sex Male 241 (51.6%)
Female 226 (48.4%)
Arterial distensibility, 10−3 mm Hg−1 186 11.1 (5.9–19.2)
MRI descending aorta pulse wave veloc-
ity, m/s
210 3.4 (2.8–4.4)
Heart rate, bpm 210 80.0 (64.6–97.8)
Age at MRI measurements, y 210 9.5 (9.1–9.9)
Carotid distensibility coefficient, mm/10−3 
kPa
385 62.3 (37.1–109.0)
Carotid intima-media thickness maximum, 
mm
393 0.5 (0.4–0.6)
Systolic blood pressure, mm Hg 386 105.0 (91.0–120.0)
Diastolic blood pressure, mm Hg 386 55.0 (44.0–69.0)
Pulse pressure, mm Hg 386 50.0 (37.0–66.0)
Age at cIMT measurement, y 393 9.2 (8.9–9.6)
Flow mediated dilatation, % 297 6.7 (1.4–13.6)
Age at FMD measurement, y 297 9.2 (8.9–9.6)
Reactive hyperemia, % 297 546.8 (239.8–982.1)
Age at reactive hyperemia measurement, y 297 9.2 (8.9–9.7)
BMI indicates body mass index; FMD, flow-mediated dilatation; cIMT, carotid 
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independently associated with aPWV. A combined model 
using the methylation status of 14 of the PWV dmCpGs 
explained 32.4% of the total variance; after adjustment 
for batch effect, position on array and cell type correction 
these 14 dmCpGs explained 42.8% of the total variance in 
PWV. Additionally correcting for maternal smoking, child’s 
Figure 1. Associations between cord blood DNA methylation and child magnetic resonance imaging (MRI) pulse wave velocity (PWV).
A, Manhattan plot showing genome-wide distribution of dmCpGs. B, Enrichment for genomic features (false discovery rate ≤0.25) relative to 
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sex and age at measurement the model explained 45.4% 
of the total variance in late childhood aPWV (Table S8).
Relationship Between Cord Blood DNA 
Methylation and Further Measures of Arterial 
Stiffness and Structure at 8 to 9 Years
To assess whether cord blood DNA methylation signatures 
were also associated with further measures of arterial struc-
ture, we analyzed methylation at birth in relation to arterial 
distensibility, pulse pressure, carotid distensibility coeffi-
cient, and carotid intima-media thickness. There was one 
dmCpG associated with arterial distensibility (measured 
in 186 children); this was cg15304800 (Table 3) located 
within the 5′ promoter region of the NOD-like receptor 
family pyrin domain containing 11 (NLRP11) gene. Two 
dmCpGs, cg21194844 (ADGRG5) and cg07652189 
(intergenic), were associated with pulse pressure. There 
were no dmCpGs with an FDR of ≤0.05 that showed a 
significant association with carotid distensibility coefficient 
(n=389) or carotid intima-media thickness (n=393). CpG 
sites associated with arterial distensibility and pulse pres-
sure (FDR of ≤0.25) were compared, but there was no 
overlap with dmCpGs associated with aPWV (Figure S1).
Associations Between Cord Blood DNA 
Methylation and Measures of Endothelial 
Function
FMD and RH assess conduit artery endothelial func-
tion as well as small vessel physiology, reflecting differ-
ent aspects of vascular biology. We, therefore, examined 
the associations of DNA methylation at birth with FMD 
and RH at 8 to 9 years. There were no dmCpGs associ-
ated with FMD or RH at an FDR of 0.05, but 11 FMD- 
and 1 RH- associated dmCpGs at an FDR of ≤0.1. The 
association between DNA methylation and systolic blood 
pressure and diastolic blood pressure was also exam-
ined. There were 3 dmCpGs associated with systolic 
blood pressure (FDR of ≤0.05; Table 4): cg14407341 
within the chimerin 2 gene (CHN2), cg05902531 within 
carboxy-terminal domain, RNA polymerase II, polypep-
tide A (CTDSP2) gene and cg12256233 within an open 
sea region, and 1 dmCpG associated with diastolic blood 
pressure—cg24745895, also within an open sea region.
Associations Between Maternal Lifestyle 
Factors and dmCpGs Associated With aPWV
Maternal BMI, weight gain in pregnancy, and mater-
nal smoking have all been linked with CVD risk in the 
offspring.17,22 We, therefore, investigated the relation-
ship between these factors and the methylation status 
of the CpGs loci associated with aPWV. Five of the 16 
aPWV-dmCpGs were associated with a number of these 
modifiable risk factors (Table 5). Cg05522885, located 
within HDGF2, was positively associated with prepreg-
nancy BMI (β=0.03 [95% CI, 0.005–0.06], P=0.02), 
cg24214214 (EIF5A) positively associated with weight 
gain during pregnancy (β=0.02 [0.005–0.03], P=0.004), 
while cg20793626 (PPM1D; β=−0.03 [−0.06 to 
−0.003], P=0.03) and cg09432349 (β=−0.03 [−0.06 
to −0.01], P=0.005) inversely associated with pregnancy 
weight gain (Figure 2A). Methylation of cg25721132 
(intergenic; β=0.27 [0.07–0.47], P=0.008) was posi-
tively associated with maternal smoking during preg-
nancy. There were no associations between maternal 
age at birth, educational attainment or parity, and aPWV-
associated dmCpG sites (data not shown).
Associations Between Maternal Dietary Factors 
and dmCpGs Associated With aPWV
Maternal dietary intake has been associated with CVD 
risk in the offspring,18–20 with components such as vitamin 
D and oily fish16,17 suggested to play a role in establish-
ing the offspring’s cardiovascular health. We investigated 
the relationships of maternal serum vitamin D, vitamin 
B12, energy intake (kcal/d), and oily fish consumption 
with the aPWV-associated dmCpGs. There was a posi-
tive association between serum vitamin D concentration 
in early pregnancy and the methylation of cg26499089 
(intergenic; β=0.009 [0.0015–0.02], P=0.018; Table 5, 
Figure 2B), but no associations between the aPWV-
associated dmCpGs and serum vitamin B12 concentra-
tions. Late pregnancy maternal oily fish consumption, 
analyzed as a continuous variable, was inversely corre-
lated with methylation of cg19669439 (BTRC) in early 






Arterial structure and stiffness
  MRI descending aorta pulse wave 
velocity, m/s
210 16 57 873
 Carotid cDC, mm/10−3kPa 385 0 0 0
 Arterial distensibility, 10−3 mm Hg−1 186 1 3 28
  Carotid intima-media thickness maxi-
mum, mm
393 0 0 11
 Pulse pressure, mm Hg 386 2 4 27
Vascular function/endothelial function
 FMD, % 296 0 11 62
 Reactive hyperemia, % 294 0 1 5
Nonspecific risk markers
 Systolic blood pressure, mm Hg 386 3 10 20
 Diastolic blood pressure, mm Hg 386 1 17 131
 Heart rate, bpm 210 1 1 27
cDC indicates carotid distensibility coefficient; FMD, flow-mediated dilatation; 
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pregnancy (β=−0.06 [−0.11 to −0.002], P=0.043), and 
oily fish intake in both early and late pregnancy with 
methylation of cg08509237, located within the first exon 
of PPT2 (palmitoyl-protein thioesterase 2), β=−0.07 
(−0.14 to −0.0098), P=0.025 and β=−0.09 (−0.14 to 
−0.04), P=0.0007, respectively (Figure 2C). EPA and 
DHA concentrations measured in blood (μg/mL) in early 
and late pregnancy were analyzed in relation to meth-
ylation of CpG sites associated with aPWV at 8 to 9 
years. There was an inverse relationship between plasma 
phosphatidylcholine DHA, but not EPA, concentration 
and the methylation status of PPT2 (cg08509237; 
Table S3). Interaction terms were examined for identified 
maternal factors and CpG methylation (adjusting for the 
main effects of both the maternal factor and CpG meth-
ylation), alongside covariates (Table S4). The interaction 
term for early pregnancy oily fish consumption with PPT2 
(cg08509237) methylation was significant at the 5% 
level (β=0.075 [0.002–0.15], P=0.045). Examination 
of the relationship between cg08509237 methylation 
and aPWV in groupings based upon early pregnancy oily 
fish consumption was consistent with a threshold effect, 
where methylation had a stronger association with aPWV 
for individuals in the group with the lowest consumption 
Table 3. Significant Associations Between Cord Blood Methylation and Measures of Cardiovascular Structure and Stiffness at 
Age 8–9 y in SWS Children
Measure of cardiovascular 
health (8–9 y)
Gene region (CpG)  




CpG island β (95% CI) P value
Adjusted 
P value
Descending aorta pulse 
wave velocity, m/s
PPM1D (cg20793626) 17 Body OpenSea −0.05 (−0.09 to −0.02) 2.40×10−08 0.018
SYBU (cg21851496) 8 First exon N_Shore −0.05 (−0.08 to −0.03) 1.90×10−07 0.04
Intergenic (cg25721132) 11 NA N_Shore 0.15 (0.04 to 0.25) 2.10×10−07 0.04
BTRC (cg19669439) 10 TSS200 Island 0.24 (0.11 to 0.37) 2.90×10−07 0.04
RAPGEF6 (cg10878312) 5 Body N_Shore 0.16 (0.06 to 0.25) 3.50×10−07 0.04
Intergenic (cg09432349) 6 NA OpenSea −0.09 (−0.15 to −0.03) 3.90×10−07 0.04
EIF5A (cg24214214) 17 TSS1500 Island 0.2 (0.09 to 0.31) 4.00×10−07 0.04
Intergenic (cg05131620) 16 NA OpenSea 0.03 (0.01 to 0.05) 4.70×10−07 0.04
Intergenic (cg26499089) 10 NA OpenSea −0.07 (−0.11 to −0.03) 5.20×10−07 0.04
HDGF2 (cg05522885) 19 TSS1500 N_Shore 0.08 (0.02 to 0.14) 5.30×10−07 0.04
MLPH (cg01504215) 2 5′UTR Island 0.06 (0.02 to 0.1) 7.90×10−07 0.048
CHD1L (cg16525692) 1 Body Island 0.23 (0.1 to 0.37) 8.60×10−07 0.048
BIN3 (cg17670421) 8 Body OpenSea 0.07 (0.03 to 0.1) 8.90×10−07 0.048
NTRK3 (cg08921491) 15 Body OpenSea −0.12 (−0.16 to −0.08) 8.90×10−07 0.048
PPT2 (cg08509237) 6 5′UTR Island 0.22 (0.13 to 0.32) 9.50×10−07 0.048
C5orf66 (cg14277284) 5 5′UTR OpenSea −0.09 (−0.14 to −0.03) 1.00×10−06 0.049
Arterial distensibility, 10−3 
mm Hg−1
NLRP11 (cg15304800) 19 TSS1500; 
5′UTR
OpenSea 0.27 (0.12 to 0.42) 2.60×10−10 0.001
Pulse pressure, mm Hg ADGRG5 (cg21194844) 16 TSS1500; 
TSS1500
OpenSea −1.26 (−1.88 to −0.63) 8.20×10−08 0.046
Intergenic (cg07652189) 4 NA OpenSea −0.87 (−1.33 to −0.4) 1.20×10−07 0.046
Regression models included maternal smoking, child’s sex, age at measurements, batch effect, position on chip and the predicted values for B cells, CD4 T cells, CD8 
T cells, monocytes, natural killer cells, and nucleated red blood cell composition. P values were adjusted for multiple testing using the Benjamini-Hochberg correction. 
SWS indicates Southampton Women’s Survey.
Table 4. Significant Associations Between Cord Blood Methylation and General Measures of Cardiovascular Health at Age 
8–9 y in SWS Children
Measure of cardiovascular 
health (8–9 y)
Gene region (CpG) mea-
sured at birth Chr. Gene feature group
Relation to 
CpG island β (95% CI) P value
Adjusted 
P value
Heart rate, bpm C6orf108 (cg09606840) 6 TSS1500; TSS1500 S_Shore 2.27 (0.65 to 3.88) 5.80×10−10 0.048
Diastolic blood pressure, 
mm Hg
Intergenic (cg24745895) 7 NA OpenSea 1.78 (1.07 to 2.49) 4.00×10−08 0.03
Systolic blood pressure, 
mm Hg
CHN2 (cg14407341) 7 Body Island 3.27 (1.83 to 4.71) 3.50×10−08 0.026
CTDSP2 (cg05902531) 12 Body Island 4.59 (2.77 to 6.41) 8.50×10−08 0.031
Intergenic (cg12256233) 7 NA OpenSea −0.46 (−0.67 to −0.24) 1.70×10−07 0.041
Regression models included maternal smoking, child’s sex, age at measurements, batch effect, position on chip and the predicted values for B cells, CD4 T cells, CD8 
T cells, monocytes, natural killer cells, and nucleated red blood cell composition. P values were adjusted for multiple testing using the Benjamini-Hochberg correction. 
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of oily fish (once every 2 to 3 months or less) in early 
pregnancy (Figure S3). The interaction term for smoking 
in pregnancy with cg25721132 (intergenic) methylation 
had a larger effect size of β=0.184 (95% CI, −0.03 to 
0.4) but did not reach significance (P=0.089).
Influence of Genetic Variation on dmCpGs 
Associated With aPWV
To investigate the influence of genetic variation on 
the 873 aPWV-dmCpGs (FDR ≤0.25) a genome-wide 
screen45 was performed to identify methylation quantita-
tive trait loci; 148 of the dmCpG sites had significant 
associations with 556 genetic variants; this included 
methylation quantitative trait loci associated with 5 of 
the 16 most significant (FDR ≤0.05) aPWV-associated 
dmCpGs (Table S5). Genetic influence at PPM1D, EIF5A, 
NTRK3, and C5orf66 was modest, with multivariate mod-
els accounting for between 3% and 14.6% of the vari-
ance in CpG methylation at different sites (Table S6). 
These genetic variants showed no independent associa-
tions with aPWV (Table S7A), and associations between 
methylation of PPM1D, EIF5A, NTRK3, and C5orf66 and 
aPWV remained significant when accounting for these 
genetic variants (Table S7B). Methylation at the aPWV-
associated intergenic CpG site cg05131620 was strongly 
influenced by genotype; methylation quantitative trait loci 
at 16 loci across a 44Kb region (Chr16:55460729-
55504521) associated in cis with methylation of 
cg05131620 (Chr16:55478717). A model including 
genotype and covariates explained 77.6% of the total 
variance in cg05131620 methylation, while a model of 
the covariates alone explained 35%. Genetic variation 
associated with cg05131620 was directly associated 
with aPWV (Table S7A). Accounting for genotype weak-
ened the significance of the association of cg05131620 
with aPWV (β=0.03 [−0.001 to 0.06], P=0.052 com-
pared with β=0.03 (0.01 to 0.04), P=7.92×10−04 without 
genotype in matched samples, Table S7B). The potential 
role of an interaction between genotype and methylation 
on aPWV levels was also examined, but no interaction 
terms were significant (Table S7C).
DISCUSSION
There is increasing evidence that an adverse early life 
environment is associated with increased risk of CVD 
in later life.22 The mechanisms by which the maternal 
environment can induce such long-term effects on the 
offspring have been suggested to involve the altered 
epigenetic regulation of genes.21 Here, we found that 
DNA methylation signatures at birth were associated 
with aPWV at age 8 to 9 years, and that a number of 
modifiable maternal risk factors, particularly aspects of 
diet and weight gain in pregnancy associated with meth-
ylation of these CpGs sites. The identification of epigen-
etic markers of future CVD risk together with modifiable 
risk factors that influence the methylation status of such 
markers may allow the early stratification of individuals at 
increased risk of CVD and potentially facilitate develop-
ment of preventive strategies to reduce the offspring’s 
later risk of CVD.
Increased arterial stiffness is one of the earliest signs 
of pathogenic changes within the structure of the vessel 
wall.9 Here, we found 16 dmCpG sites which were related 
to aPWV. The dmCpG most significantly associated 
with aPWV was located within PPMID, which encodes 
a serine/threonine phosphatase that dephosphorylates 
proteins involved in the DNA damage response. Both 
animal and human studies suggest that impairment to 
the DNA damage response and repair pathways is linked 
to increased arterial stiffness and elevated BP.51,52 Here, 
we found that higher PPMID gene body methylation was 
associated with decreased aPWV. As gene body DNA 
methylation is generally associated positively with tran-
scription, this would suggest that, in line with previous 
Table 5. Associations Between Maternal Factors and dmCpG Sites Associated With Aortic PWV
 
Gene region (CpG) mea-




CpG island n β (95% CI) P value
Maternal lifestyle exposure
 Women’s prepregnancy BMI, kg/m2 HDGF2 (cg05522885) 19 TSS1500 N_Shore 470 0.03 (0.00505 to 0.06) 0.020
 Pregnancy weight gain, kg unnamed (cg09432349) 6 NA OpenSea 448 −0.03 (−0.06 to −0.01) 0.005
PPM1D (cg20793626) 17 Body OpenSea 448 −0.03 (−0.06 to −0.0032) 0.031
EIF5A (cg24214214) 17 TSS1500 Island 448 0.02 (0.00552 to 0.03) 0.004
 Smoking in pregnancy unnamed (cg25721132) 11 NA N_Shore 470 0.27 (0.07 to 0.47) 0.008
Maternal nutritional exposure
 EP: Oily fish, portions/wk PPT2 (cg08509237) 6 5′UTR Island 386 −0.07 (−0.14 to −0.0098) 0.025
BTRC (cg19669439) 10 TSS200 Island 386 −0.06 (−0.11 to −0.0021) 0.043
 LP: Oily fish, portions/wk PPT2 (cg08509237) 6 5′UTR Island 463 −0.09 (−0.14 to −0.04) 7.04×10−04
 EP vitamin D, nmol/L unnamed (cg26499089) 10 NA OpenSea 372 0.00871 (0.00151 to 0.02) 0.018
Multivariate analysis correcting for array batch, position, blood cell components (B cell CD4T CD8T Mono NK nRBC), sex of child, smoking in pregnancy. BMI indicates 
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Figure 2. Associations between maternal factors and dmCpG methylation.
Associations between (A) pregnancy weight gain, PPM1D dmCpG methylation, and later associations with magnetic resonance imaging (MRI) 
pulse wave velocity (PWV); (B) early pregnancy circulating vitamin D levels, cg26499089 dmCpG methylation, and later associations with MRI 
PWV; and (C) late pregnancy maternal oily fish consumption compared with PPT2 (palmitoyl-protein thioesterase 2) dmCpG methylation, and 
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findings, higher expression of PPMID and a suppres-
sion of the DNA damage response is associated with 
increased arterial stiffness. Moreover, pathway analysis 
revealed that DNA repair was the most significantly 
enriched pathway among the dmCpGs that were associ-
ated with aPWV, including DNA repair genes RAD23A, 
RAD51B, CHD1L, REV1, and XPA.
An increase in aPWV of 1 m/s has been associated 
with a 15% increase in relative risk of cardiovascular-
related mortality.53 In our data, cg20793626 (PPM1D), 
the dmCpG most strongly associated aPWV, was asso-
ciated with an increase in aPWV of 0.06 m/s, which 
equates to an increase in cardiovascular-related mor-
tality risk of 0.9% per 1% decrease in DNA methyla-
tion. Given that PPM1D DNA methylation has a range 
of 12% within our cohort, this potentially represents a 
substantial variation in risk across the cohort. Moreover, 
combining cg20793626 in a multivariate model with 13 
further aPWV-associated dmCpGs alongside covari-
ates explained 45.4% of the total variance observed 
in aPWV, suggesting that the methylation signature 
associated with aPWV may have utility as a predictor of 
future cardiovascular health.
Several of the dmCpGs in the multivariate model 
have robust CVD links; cg17670421 is located within 
the BIN3 gene, which has been reported to play a role 
in cardiomyocyte homeostasis and is downregulated in 
cardiomyopathy, while plasma BIN1 levels have been 
shown to predict heart failure.54 Additionally, methyla-
tion within MLPH was found to have a strong predic-
tive relationship with the incidence of coronary heart 
disease in a meta-analysis of 11 461 adults. The CpG 
site in MLPH we identified in our study was not present 
on the array used by Agha et al55; however, the discov-
ery that further CpG sites within this gene are linked 
to PWV does support methylation status of the MLPH 
gene as a marker of CVD risk.
The environment, particularly the early life environ-
ment, has also been shown to influence DNA methylation 
as well as the phenotype and is a key determinant of an 
individual’s risk of developing CVD in adult life.56 Expo-
sure to maternal obesity is strongly linked to death from 
coronary heart disease, stroke, and other cardiovascular 
events in the adult offspring,57,58 while maternal weight 
gain in pregnancy is associated with increased left ven-
tricular mass in the child at birth.59 Of the 16 dmCpG 
sites that were associated with aPWV, one was also 
associated with prepregnancy BMI and 3 were associ-
ated with weight gain during pregnancy, suggesting an 
influence of maternal body composition both before and 
during pregnancy. Maternal BMI and excessive weight 
gain during pregnancy are major drivers of childhood 
adiposity,60,61 which has also been linked with later CVD 
risk.62 However, adjusting for the child’s BMI did not 
attenuate the associations between DNA methylation 
and aPWV in our analyses. One interpretation is that the 
apparent influence of maternal BMI or weight gain dur-
ing pregnancy on these DNA methylation signatures may 
involve pathways that are independent of the child’s BMI.
Exposure to maternal smoking during pregnancy 
has been associated with reduction in arterial elastic-
ity and elevated systolic blood pressure in children.63,64 
The present findings show that maternal smoking during 
pregnancy was associated with increased methylation of 
cg25721132, an intergenic dmCpG for which increased 
methylation was associated with greater aPWV. This sug-
gests that maternal smoking may influence arterial stiff-
ness at least in part through epigenetic processes.
A number of studies have reported associations 
between maternal diet and later CVD risk in the offspring: 
for example, we previously showed that increased oily 
fish consumption in late pregnancy was associated with 
a reduction in the child’s PWV,19 while other studies have 
shown that dietary supplementation with omega-3 poly-
unsaturated fatty acid in adults reduces the incidence of 
cardiovascular events, as well as lowering BP and heart 
rate.65,66 PPT2 encodes palmitoyl-protein thioester-
ase-2 involved in fatty acid elongation. Here, we found 
that higher methylation of cg08509237 located within 
the 5′UTR of PPT2, for which methylation status was 
related to aPWV, was associated with decreased intake 
of oily fish in early and late pregnancy. Consistent with 
this, a lower DHA concentration in late pregnancy, for 
which oily fish is the major dietary source,15 was also 
associated with increased PPT2 methylation. The asso-
ciation of cg08509237 (PPT2) methylation at birth with 
later aPWV varied according to consumption of oily fish 
in early pregnancy, with further analysis indicating that 
consumption above a threshold of one or more portions 
per month during early pregnancy weakened the asso-
ciation between methylation and increased aPWV. This 
threshold effect was observed in relation to early, but not 
late, pregnancy—suggesting that early pregnancy is a 
critical developmental window where diet may influence 
the way in which DNA methylation relates to later aPWV. 
Interestingly, genetic variation within PPT2 has previously 
been linked to docosapentaenoic acid (22:5n-3) levels 
in a trans-ethnic meta-analysis that suggested a role for 
PPT2 in polyunsaturated fatty acid metabolism.67 Oily 
fish consumption in early pregnancy was also associ-
ated with the methylation status of cg19669439, which 
is located within the promoter region of β-transducin 
repeat containing E3 ubiquitin protein ligase (BTRC), 
one of the top dmCpG sites associated with later aPWV. 
BTRC (also known as β-TrcP1) mediates ubiquitination 
and degradation of β-catenin, which plays an essen-
tial role in heart development as well as cardiac tissue 
homoeostasis in adults.68 Moreover, reduced DNA meth-
ylation and increased gene expression of BTRC within 
peripheral blood has been reported in patients with cor-
onary artery disease.69 Thus, these findings suggest a 
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altered epigenetic regulation of cardiovascular develop-
ment in the fetus, and childhood measures of CVD risk. 
Members of the PPAR family of fatty acid-binding tran-
scription factors interact with both DNA methyl transfer-
ases70 and demethylases,71 while supplementation with 
fatty acids has been directly linked to changes in DNA 
methylation.72
Fixed genetic variation can also influence DNA meth-
ylation patterns,45 and we identified methQTLs associ-
ated with 5 of the 16 aPWV-associated CpG sites. Taken 
together our results show that both prenatal modifiable 
CVD risk factors and fixed genetic variants can influence 
the PWV-associated methylation signature in infants; 
however, after adjusting our model to account for these 
factors, associations between methylation at birth and 
later cardiovascular measures generally remained sig-
nificant. Identifying additional factors that modulate the 
methylation status at these sites, together with a better 
understanding of whether such epigenetic changes play 
a causal role in the development of increased arterial 
stiffness, or are simply markers of this process, will allow 
us to further refine such signatures and facilitate their 
utility as prognostic tools.
There are several strengths of this study. It is the 
first epigenome wide association study to identify DNA 
methylation changes at birth that are associated with 
extensive measures of both cardiovascular structure and 
function in late childhood, permitting the detection of 
early epigenetic markers associated with cardiovascular 
risk in children. Prior studies that have examined methyl-
ation changes in relation to CVD risk have focussed upon 
mid- to late-adulthood methylation changes and asso-
ciations with concurrent CVD, when damage to vessel 
walls is more pronounced. Second, aPWV was measured 
in this study by magnetic resonance imaging allowing for 
a true measurement of vascular lumen length (distance 
between the flow acquisitions)—this is in contrast to other 
PWV techniques that rely upon an approximated value 
from a body surface measurement, which has implica-
tions for the accuracy of the derived velocity.3,73 Addition-
ally, we used the Illumina 850K array, which has greater 
coverage of CpG sites in important regulatory regions of 
the genome associated with cardiovascular risk than pre-
vious genome-wide studies that used the Illumina 27K or 
450K arrays. For example, the strongest associations we 
observed were from probes unique to the Illumina 850K 
array, and almost half of our significant associations are 
not represented on the 450K platform. In our combined 
model, 6 of the 14 CpG sites are not present on the 450K 
platform (cg20793626, cg21851496, cg09432349, 
cg05131620, cg01504215, cg17670421), including 
PPM1D—the strongest association with aPWV. Whether 
these epigenetic markers are causally involved in mediat-
ing the changes in arterial stiffness is not known. None-
theless, as markers of early vascular pathophysiology 
they may be useful in early identification of individuals 
with an increased CVD risk during the lifecourse and 
assist in the evaluation of potential interventions to 
reduce this risk.
Our study has several limitations. First, DNA meth-
ylation was examined in cord blood and, although we 
have corrected our analysis for cord blood cell composi-
tion, the longer-term methylation status and functional 
significance of these changes is unknown. DNA meth-
ylation changes in nucleated blood cells may reflect 
changes in immune function, or be related to inflamma-
tion, so further work is needed to elucidate the mecha-
nistic links between the dmCpG sites we identified and 
alterations in an individual’s cardiovascular health. Fur-
thermore, our observations represent a child’s cardio-
vascular phenotype at a single time point at age 8 to 
9 years, rather than a longitudinal assessment of car-
diovascular health. The children we studied were all of 
White ethnicity and extension to and replication in fur-
ther cohorts is necessary to validate and determine the 
generalizability of these observations. Additionally, we 
were not able to examine gene expression in cord blood 
in relation to these DNA methylation changes, nor was 
data available on maternal DNA methylation patterns to 
examine epigenetic regulation of marks identified here 
in relation to the maternal methylome.
Conclusions
To our knowledge, this is the first epigenome wide asso-
ciation study to investigate the relationship between 
perinatal DNA methylation with markers of cardiovas-
cular structure and function in childhood. The findings 
showed that the methylation status of individual CpG loci 
in umbilical cord blood at birth were predictive of arterial 
stiffness in children at age 8 to 9 years, with a multivariate 
model containing 14 dmCpGs as well maternal and array 
covariates including cell type correction explained 45.4% 
of the variance in the child’s aPWV. Furthermore, several 
of the aPWV-associated dmCpGs were also associated 
with a range of modifiable risk factors, including maternal 
oily fish intake, suggesting that methylation signatures at 
birth predictive of later CVD risk are influenced by mater-
nal health, diet, and lifestyle choices. The identification of 
such modifiable lifestyle factors before pregnancy, and 
in both early as well as late pregnancy, may permit the 
development of new intervention strategies to improve 
the cardiovascular health of the offspring.
Perspectives
DNA methylation patterns at birth have been related 
to health outcomes in later life, potentially reflecting 
exposures in utero and thus aspects of the maternal 
environment. We conducted the first epigenome-wide 
association study of DNA methylation signatures at birth 
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and function in children aged 8 to 9 years. DNA meth-
ylation patterns at birth were related to child’s BP, pulse 
pressure, arterial distensibility, and aPWV; early mark-
ers of cardiovascular risk. Maternal influences modified 
these methylation patterns, in particular, oily fish con-
sumption during pregnancy, with an interaction between 
early pregnancy oily fish consumption and later childhood 
pulse wave velocity. Taken together, this work identifies 
predictive biomarkers of later CVD risk in children and 
demonstrates the potential for maternal factors such as 
diet in pregnancy to modify these markers and promote 
cardiovascular health in the next generation.
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